Dose-dependent cytotoxic and mutagenic effects of antineoplastic alkylating agents on human lymphoblastoid cells

B J Sanderson1, K J Johnson, W D Henner

  • 1Division of Hematology and Medical Oncology, Oregon Health Sciences University, Portland 97201.

Insights

Eight antineoplastic alkylating agents were tested for mutagenicity and cytotoxicity in human cells. All agents were found to be both cytotoxic and mutagenic, with varying mutagenic efficiency.

Area of Science:

  • Pharmacology
  • Toxicology
  • Genetics

Background:

  • Alkylating agents used as antineoplastics are suspected human carcinogens based on animal and human studies.
  • Quantitative data on mutagenicity and its correlation with cytotoxicity in normal human cells is limited.

Purpose of the Study:

  • To quantify the mutagenic and cytotoxic effects of eight antineoplastic alkylating agents on human lymphoblastoid cells.
  • To assess the correlation between mutagenicity and cytotoxicity of these agents.

Main Methods:

  • Human lymphoblastoid cells (WIL2-NS) were exposed to varying doses of eight antineoplastic alkylating agents.
  • Cell killing (cytotoxicity) and mutation induction at the hypoxanthine-guanine phosphoribosyltransferase (HPRT) locus were measured.
  • IC50 values (concentration for 50% inhibition of survival) were calculated for each drug.

Main Results:

  • All eight alkylating agents demonstrated dose-dependent cytotoxicity and induced detectable mutations.
  • IC50 values ranged from 4 x 10(-7) M (nitrogen mustard) to 5 x 10(-4) M (busulfan) after 1-hour exposure.
  • At equitoxic doses, induced mutant frequencies varied, with 1,3-bis(2-chlorethyl)-1-nitrosourea (BCNU) showing approximately 3 x 10(-6) and busulfan/cisplatin showing 2 x 10(-5).

Conclusions:

  • Antineoplastic alkylating agents are both cytotoxic and mutagenic to human cells.
  • A strong correlation exists between the cytotoxicity and mutagenicity of these agents.
  • The mutagenic efficiency of these bifunctional alkylating agents varies significantly.

Related Concept Videos

Treatment Resistant Cancers02:56

Treatment Resistant Cancers

Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
Drugs that Destabilize Microtubules01:10

Drugs that Destabilize Microtubules

Microtubules are dynamic structures and can be regulated by microtubule targeting agents (MTAs). Microtubule destabilizing drugs are a class of MTAs that destabilize and prevent microtubules' polymerization. Both natural and synthetic chemicals can be found under this class of drugs. Vincristine and vinblastine, two vinca alkaloids, and colchicine were among the first to be discovered. These drugs can affect cells in various ways, either by inducing a change in cell morphology, preventing...
Nucleotide Excision Repair01:38

Nucleotide Excision Repair

DNA Distortion and Damage
Cells are regularly exposed to mutagens—factors in the environment that can damage DNA and generate mutations. UV radiation is one of the most common mutagens and is estimated to introduce a significant number of changes in DNA. These include bends or kinks in the structure, which can block DNA replication or transcription. If these errors are not fixed, the damage can cause mutations, which in turn can result in cancer or disease depending on which sequences are...
Mutagenicity and Carcinogenicity01:25

Mutagenicity and Carcinogenicity

Mutagenicity and carcinogenicity refer to the ability of drugs to cause genetic defects and induce cancer, respectively. The International Agency for Research on Cancer (IARC) classifies agents into four groups based on their carcinogenic potential. Group 1 agents are known human carcinogens; group 2A agents are probably carcinogenic to humans; group 3 agents lack data to support their role in carcinogenesis; and group 4 includes agents for which data support that they are not likely to be...
Drug Toxicity: Dose-Dependent Reactions01:24

Drug Toxicity: Dose-Dependent Reactions

Drug toxicities can be stratified into pharmacological, pathological, or genotoxic based on their mechanisms. The incidence and severity of these toxicities generally increase with the drug's concentration in the body and exposure time.Pharmacological toxicity is evident when the therapeutic effects of drugs overshoot into adverse reactions in a predictable, dose-dependent manner. Central nervous system (CNS) depression from barbiturates is a classic example, with effects escalating from...
Spontaneous and Induced Mutations01:30

Spontaneous and Induced Mutations

Spontaneous mutations arise infrequently during DNA replication due to errors in the process. A key factor behind these errors is tautomeric shifts in nitrogenous bases, where bases transition from keto to enol forms or amino to imino forms. This shift can alter base-pairing rules, leading to mutations. Additionally, reactive oxygen species (ROS) arising from aerobic metabolism can damage DNA, resulting in depurination (loss of a purine base) or depyrimidination (loss of a pyrimidine base).